Stifel has raised its price target for Workiva's stock to $98, reflecting strong growth prospects for the company. This adjustment is significant as it indicates investor confidence in Workiva's ability to expand and succeed in the market, which could attract more investors and positively impact the stock's performance.

Stifel has raised its price target for Procore Technologies to $85 following the company's strong earnings report. This adjustment reflects confidence in Procore's growth potential and solid performance, which is significant for investors looking for promising opportunities in the tech sector.

Stifel has lowered its price target for Klaviyo's stock to $40, reflecting a cautious outlook for the company's performance in 2026. This adjustment signals concerns about Klaviyo's growth potential and could impact investor confidence. As analysts adjust their forecasts, it highlights the challenges the company may face in a competitive market, making it a significant development for stakeholders.

Expeditors International has received a price target increase from Stifel, raising it from $114 to $130. This adjustment reflects Stifel's confidence in the company's growth potential and market performance, which is significant for investors looking for promising opportunities in the logistics sector.

HubSpot's stock has taken a hit following Stifel's decision to lower its price target due to concerns about the company's growth prospects. This adjustment reflects broader worries in the market about how well HubSpot can maintain its momentum in a competitive landscape. Investors are closely watching these developments, as they could signal potential challenges ahead for the company.

Stifel has raised its price target for Pursuit Attractions and Hospitality stock to $42, reflecting confidence in the company's growth potential. This adjustment is significant as it indicates analysts' positive outlook on the company's performance and could attract more investors, boosting market interest and potentially driving the stock price higher.

Stifel has raised its price target for Western Gas Partners to $43 following strong financial results. This adjustment reflects confidence in the company's performance and growth potential, which is significant for investors looking for promising opportunities in the energy sector.

Stifel has reduced its price target for X4 Pharmaceuticals from $9.00 to $7.50, indicating a less optimistic outlook for the company's stock performance. This adjustment reflects concerns about the company's future growth and market conditions, which could impact investor confidence and trading activity. Such changes in price targets are significant as they can influence investor decisions and the overall market perception of the company.